Related Experiment Video
Updated: Jun 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke
Marlon S Mathews1, Jitendra Sharma, Kenneth V Snyder
1Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, USA.
Insights
Endovascular therapy is a safe and effective treatment for ischemic stroke within 3 hours of symptom onset, especially when intravenous tissue plasminogen activator (tPA) fails or is contraindicated. This approach offers a low risk of symptomatic intracranial hemorrhage (ICH).
Area of Science:
- Neurology
- Interventional Radiology
Background:
- Ischemic stroke requires timely intervention.
- Intravenous thrombolysis (IV tPA) is a standard treatment but has limitations.
- Endovascular therapy offers an alternative for select patients.
Purpose of the Study:
- To evaluate the safety, effectiveness, and practicality of endovascular therapy for ischemic stroke.
- To assess outcomes in patients treated within 3 hours of symptom onset, particularly when IV tPA is contraindicated or fails.
Main Methods:
- Retrospective chart review of 94 patients undergoing endovascular therapy within 3 hours of ischemic stroke onset.
- Analysis of outcomes including recanalization rates, intracranial hemorrhage (ICH), procedural complications, and functional outcomes (modified Rankin Scale, NIHSS).
- Interventions included intra-arterial thrombolysis, mechanical thrombectomy, and angioplasty, sometimes combined with IV tPA or glycoprotein IIb/IIIa inhibitors.
Main Results:
- Successful recanalization was achieved in 70% of patients with significant occlusion.
- Symptomatic intracranial hemorrhage (ICH) occurred in 5.3% of patients.
- Overall mortality was 26.6%.
- At discharge, 36.7% of patients had a modified Rankin Scale score of 2 or less, with an average NIHSS improvement of 8 points.
Conclusions:
- Endovascular therapy is a safe, effective, and practical option for ischemic stroke within 3 hours when IV tPA is contraindicated or fails.
- The risk of symptomatic ICH is low and should be weighed against the poor prognosis of untreated patients.
Objective:
This study assesses the safety, effectiveness, and practicality of endovascular therapy for ischemic stroke within the first 3 hours of symptom onset.
Methods:
A retrospective chart review (January 2000-July 2008) was performed of 94 consecutive patients who had endovascular therapy within 3 hours after acute ischemic stroke onset. Endovascular therapy was administered in patients in whom intravenous (IV) thrombolysis failed or was contraindicated. Outcome measures analyzed were recanalization rate, intracranial hemorrhage (ICH) rate, procedural complications, modified Rankin Scale score, National Institutes of Health Stroke Scale (NIHSS) score, and mortality rate.
Results:
The study included 41 male and 53 female patients with a mean age of 68 years (age range, 13-98 years). The mean NIHSS score at the time of admission was 14.7. Eight-three patients had anterior circulation ischemic events, and 11 had posterior circulation ischemic events. The cause was determined to be arterioembolic in 21 patients (22%), cardioembolic in 45 (48%), arterial dissection in 2, left-to-right cardiac shunt in 1, and unknown in 25 (27%). Endovascular interventions included intra-arterial (IA) pharmacological thrombolysis (n = 44), mechanical thrombolysis (Merci Retrieval System, intracranial or extracranial stent, microwire) (n = 79), and intracranial or extracranial angioplasty (n = 32) in various combinations. The mean time from stroke onset to angiogram was 72 minutes. Thirteen patients received a half dose (n = 8) or full dose (n = 5) of IV thrombolysis (tissue plasminogen activator [tPA]) in conjunction with endovascular therapy. Twenty-two patients received IA or IV adjunctive glycoprotein IIb/IIIa inhibitor (eptifibatide). Partial-to-complete recanalization (Thrombolysis in Myocardial Infarction scale score of 2 or 3) was achieved in 62 of 89 of patients (70%) presenting with significant occlusion (Thrombolysis in Myocardial Infarction scale score of 0 or 1). Postprocedure symptomatic ICH occurred in 5 patients (5.3%), which was purely subarachnoid hemorrhage in 3 patients. Of these, 2 received IA tPA in conjunction with Merci Retrieval System passes; the others each received IA tPA, mechanical thrombectomy (guidewire), or extracranial angioplasty. The total mortality rate including procedural mortality, progression of disease, and other comorbidities was 26.6%. Sixteen patients (17%) were discharged home, 49 (52%) to rehabilitation, and 4 (4%) to long-term care facilities. Overall, 36.7% had a modified Rankin Scale score of 2 or less at discharge. The mean NIHSS score at discharge was 6.5, representing an overall 8-point improvement on the NIHSS.
Conclusion:
Endovascular therapy within the first 3 hours of stroke symptom onset in patients in whom IV tPA therapy is contraindicated or fails is safe, effective, and practical. The risk of symptomatic ICH is low and should be viewed relative to the poor prognosis in this group of patients.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Acute Coronary Syndrome I: Introduction
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

